PTPRK and ovarian carcinoma: The present study aimed to examine the expression of PTPRK in ovarian cancer cell lines resistant to: CIS, PAC, DOX, TOP, VIN, and MTX and the impact of this molecule expression on total phosphotyrosine (pTYR) level and drug resistance.